MENU
+Compare
VKTX
Stock ticker: NASDAQ
AS OF
Aug 8 closing price
Price
$37.89
Change
+$2.33 (+6.55%)
Capitalization
4.26B

VKTX Viking Therapeutics Forecast, Technical & Fundamental Analysis

Viking Therapeutics Inc is a healthcare service provider... Show more

Industry: #Biotechnology
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VKTX with price predictions
Aug 08, 2025

Aroon Indicator for VKTX shows an upward move is likely

VKTX's Aroon Indicator triggered a bullish signal on August 08, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 176 similar instances where the Aroon Indicator showed a similar pattern. In of the 176 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 07, 2025. You may want to consider a long position or call options on VKTX as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VKTX just turned positive on August 08, 2025. Looking at past instances where VKTX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for VKTX crossed bullishly above the 50-day moving average on July 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VKTX advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where VKTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VKTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VKTX broke above its upper Bollinger Band on August 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VKTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.356) is normal, around the industry mean (18.696). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). VKTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (286.048).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VKTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VKTX is expected to report earnings to rise 15.22% to -66 cents per share on October 22

Viking Therapeutics VKTX Stock Earnings Reports
Q3'25
Est.
$-0.67
Q2'25
Missed
by $0.13
Q1'25
Missed
by $0.08
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.02
The last earnings report on July 23 showed earnings per share of -57 cents, missing the estimate of -44 cents. With 7.02M shares outstanding, the current market capitalization sits at 4.26B.
A.I. Advisor
published General Information

General Information

a company that engages in the development of therapies for metabolic and endocrine disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9920 Pacific Heights Boulevard
Phone
+1 858 704-4660
Employees
27
Web
https://www.vikingtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHEIX13.170.09
+0.69%
T. Rowe Price Hedged Equity I
NINAX21.000.11
+0.53%
Neuberger Berman Intrinsic Value A
AMPFX44.500.09
+0.20%
American Funds AMCAP F1
NCVLX12.36-0.01
-0.08%
Nuance Concentrated Value Institutional
OBIIX11.46-0.05
-0.43%
Oberweis International Opps Instl

VKTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with CRNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+6.55%
CRNX - VKTX
46%
Loosely correlated
-3.69%
SYRE - VKTX
46%
Loosely correlated
N/A
LRMR - VKTX
45%
Loosely correlated
-2.19%
GPCR - VKTX
45%
Loosely correlated
+0.68%
ROIV - VKTX
44%
Loosely correlated
-0.52%
More